ATHIRA PHARMA
Dead / Abandoned — Abandoned — no statement of use filed (as of 04 May 2026)
What this means for you
This application is over — abandoned 04 May 2026. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97894381
- Mark type
- Word mark
- Filed
- 18 Apr 2023
- Published for opposition
- 06 Aug 2024
- Abandoned
- 04 May 2026
- Attorney of record
- Kevin S. Costanza
Goods and services
- Class 042 — Scientific and technological services: Pharmaceutical research and development; pharmaceutical drug development services
Owner
- LEONABIO, INC., BOTHELL, WA, US
- Athira Pharma, Inc., Seattle, WA, US
- Athira Pharma, Inc., Seattle, WA, US
Prosecution history
- 04 May 2026 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 04 May 2026 — ABANDONMENT - NO USE STATEMENT FILED
- 15 Apr 2026 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 14 Aug 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 13 Aug 2025 — SOU EXTENSION 2 GRANTED
- 13 Aug 2025 — SOU EXTENSION 2 FILED
- 13 Aug 2025 — SOU TEAS EXTENSION RECEIVED
- 05 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 05 Mar 2025 — SOU EXTENSION 1 GRANTED
- 04 Mar 2025 — SOU EXTENSION 1 FILED
- 04 Mar 2025 — SOU TEAS EXTENSION RECEIVED
- 01 Oct 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 06 Aug 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 06 Aug 2024 — PUBLISHED FOR OPPOSITION
- 17 Jul 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED